L2 Asset Management, LLC Royalty Pharma PLC Transaction History

L2 Asset Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$32.77 - $39.4 $358,733 - $431,311	10,947 Added 19.51%	67,057 $2.42 Million
Q4 2022 Feb 14, 2023	SELL	$39.17 - $44.04 $66,158 - $74,383	-1,689 Reduced 2.92%	56,110 $2.22 Million
Q3 2022 Nov 10, 2022	BUY	$39.88 - $44.65 $2.31 Million - $2.58 Million	57,799 New	57,799 $2.32 Million

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of L2 Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on L2 Asset Management, LLC with notifications on news.